GlassScriptPhysician profile
Arthur J Ronan
NPI 1346283074
$5,956.86
in general payments reported to CMS, 2019-2025
52 companies · $982 in 2025
The $982 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $605 · 2020: $120 · 2021: $1,031 · 2022: $1,124 · 2023: $1,192 · 2024: $903 · 2025: $982.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,077.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,076.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,365.63 | 2021-2025 | Botox, Vraylar, Ubrelvy |
| Amgen INC. | $818.00 | 2019-2025 | Repatha, Otezla, Otezla |
| Novo Nordisk INC | $421.09 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $295.30 | 2019-2025 | Zepbound, Mounjaro, Trulicity |
| Pfizer INC. | $262.53 | 2019-2025 | |
| Merz North America, INC. | $202.01 | 2023-2025 | Xeomin |
| Esperion Therapeutics, INC. | $132.79 | 2021 | |
| Novartis Pharmaceuticals Corporation | $129.73 | 2019-2025 | |
| Eisai INC. | $128.70 | 2021-2025 | |
| Abbott Laboratories | $122.74 | 2022-2025 | Freestyle Libre 3 |
| Grifols USA, LLC | $118.24 | 2022-2024 | Prolastin-C Liquid |
| Antares Pharma, INC. | $117.29 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Janssen Pharmaceuticals, INC | $108.71 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $102.68 | 2019-2023 | |
| Galderma Laboratories, L.P. | $92.61 | 2021-2025 | Dysport |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Ronan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.